Chimica Oggi-Chemistry Today
Agro FOOD Industry Hi Tech
p. 5-7 / Oligos & Peptides
Peptide therapeutics market:
forecast and analysis 2015-2025

Future Market Insights, Healthcare and Medical Devices

KEYWORDS: Peptide therapeutics market, use of peptides in therapeutics, future directions of peptide therapeutics, peptide therapeutics in oncology, peptide therapeutics in metabolic disorders, peptide therapeutics market size and forecast.
ABSTRACT: This article discusses the state of the peptide therapeutics market, with special emphasis on the application is managing metabolic disorders and cancers. The wide-ranging application of peptides in numerous disease indications has bolstered the global peptide therapeutics market. Pharma companies are increasing their research and development spending to gain a stronghold in a market which was valued at $17.5 Bn in 2015. Along with offering a detailed analysis of the peptide therapeutics market, this article offers market figures on the basis of disease indication and 10-year region-wise forecast in the three largest markets – North America, Western Europe, and Asia Pacific excluding Japan (APEJ).


Peptides are growing in prominence in the pharmaceutical research and development (R&D) sector, owing to their wide-ranging applications in the effective management of a number of diseases. Peptide therapeutics are easy to produce as compared to protein-based biopharmaceuticals, offering a substantial cost advantage to pharma companies.

Over the last two decades or so, innovation in development of peptides, such as multifunctional and cell penetrating peptides, has opened up a plethora of opportunities for use of peptides in therapy. Development of peptide therapeutics is also growing on account of evolution of hybrid technology – which combines both solid and liquid synthesis of naturally occurring peptides. Peptide conjugation and modification strategies offer the potential to unlock the full potential of peptides for therapeutic benefit.

The global peptide therapeutics market was valued at $17.5 billion in 2015. It is expected to increase at a compound annual growth rate (CAGR) of 10.3% during 2015-2025 and total US$ 47 billion in revenues by 2025.

The key macroeconomic factors driving the global peptide therapeutics market are increasing healthcare expenditure and prioritisation of healthcare sector in developing countries. For example, healthcare expenditure in Brazil and India – two of the fastest growing economies – went up by 0.3% and 0.2% respectively in 2014 over 2013 (1)(2).
According to a survey published in, over 300 companies were involved in developing 292 peptide-based drugs in 780 oncology projects (3). Leading players in the peptide therapeutics market are focusing on developing targeted, therapy-related peptide therapeutics.

Peptide therapeutics is one of the fastest growing segments in the pharmaceutical industry. The main disease indications that are driving the demand for peptide therapeutics are cancer, metabolic disorders, and central nervous systems. In 2015, these three disease indications accounted for over 80% revenue share of the global peptide therapeutics market.

Obesity levels have reached alarming proportions...In order to continue reading this article please register to our website – registration is for free and no fees will be applied afterwards to download contents.

Teknoscienza Mobile
Teknoscienze - Viale Brianza 22, Milano - ITALY - P.IVA 06817720151
Teknoscienze S.r.l. © 2012 - tutti i diritti riservati - web terms & conditions - privacy - Credits